GOVX
GeoVax Labs (GOVX)
$
98About GeoVax Labs (GOVX)
GeoVax Labs, Inc. is a clinical-stage biotechnology company, which engages in the development of human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. It focuses on preventive vaccines against hemorrhagic fever viruses such as Ebola, Sudan, Marburg, and Lassa fever, the Zika virus and malaria, and human immunodeficiency virus, as well as immunotherapies for solid tumor cancers. The company was founded in June 1988 and is headquartered in Smyrna, GA.
Details
Daily high
$2.03
Daily low
$1.91
Price at open
$2.00
52 Week High
$11.18
52 Week Low
$1.09
Market cap
16.9M
Dividend yield
0.00%
Volume
361,810
Avg. volume
872,262
P/E ratio
-.15
GeoVax Labs News
Details
Daily high
$2.03
Daily low
$1.91
Price at open
$2.00
52 Week High
$11.18
52 Week Low
$1.09
Market cap
16.9M
Dividend yield
0.00%
Volume
361,810
Avg. volume
872,262
P/E ratio
-.15